Clinical trials
Active, not recruiting Carcinoma, Merkel Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| National Cancer Institute (NCI) | 3 |
| Melanoma and Skin Cancer Trials Limited | 2 |
| University of Washington | 2 |
| AdventHealth Translational Research Institute | 1 |
| British Columbia Cancer Agency | 1 |
| Checkpoint Therapeutics, Inc. | 1 |
| Fujifilm Pharmaceuticals U.S.A., Inc. | 1 |
| Gruppo Oncologico del Nord-Ovest | 1 |
| ImmunityBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 24 |
| Melanoma | 7 |
| Basal Cell Carcinoma | 5 |
| Skin Neoplasms | 5 |
| Cutaneous Squamous Cell Carcinoma | 4 |
| Neuroendocrine Tumors | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Renal Cell | 3 |
| Carcinoma, Transitional Cell | 3 |
| Carcinoma | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.